Novel oral medication could provide a new treatment option for people with PBC who have not achieved the recommended treatment...
Company’s radiopharmaceutical manufacturing facility now operational, supplying doses for the Phase 3 SPLASH trial – view the facility at manufacturing.pointbiopharma.com...
Joint Development Committee of SELLAS and Merck Agreed on Study Completion and Overall Operational Path Towards Data Analysis Interim Data...
-- Phase 3 ENABLAR-2 Clinical Trial for 2nd Line Treatment of AR+ER+HER2- Metastatic Breast Cancer Expected to Commence During First Quarter...
SAN DIEGO, CA, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical...
NASHVILLE, Tenn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
Toronto, Ontario--(Newsfile Corp. - February 1, 2022) - Inkblot Technologies (Inkblot), Canada's fastest growing virtual mental health provider, is excited...
Tau has been shown to be important in the development of Alzheimer's Disease.Eradication of tau accomplished without reducing levels of...
Toronto, Ontario--(Newsfile Corp. - February 1, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Revenue Management Leader Helps Life Sciences Companies Operationalize Price Transparency Processes and Adapt to New Market-Driven Demands SAN MATEO, Calif.--(BUSINESS...
DUNMORE, Pa.--(BUSINESS WIRE)--Huntzinger Management Group, Inc. (Huntzinger), a leader in healthcare IT advisory, managed, implementation and staffing services and a...
Conference Call and Webcast Scheduled for 1:30 p.m. PST SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology...
--Leader in women’s health shines spotlight on preventive screenings in commercial created by women, for women premiering during one of...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 1, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
GENEVA, SWITZERLAND / ACCESSWIRE / February 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...